-
-
-
ISO 9001:2015 CERTIFIED
Meet ASTANDARDS at
CPHI India : November 23-25, 2026
IICC Yashobhoomi, Dwarka, New Delhi, India
ISO 9001:2015 CERTIFIED
Meet ASTANDARDS at
CPHI India : November 23-25, 2026
IICC Yashobhoomi, Dwarka, New Delhi, India
Carfilzomib API is a selective proteasome inhibitor used in the treatment of relapsed or refractory multiple myeloma. It induces apoptosis in cancer cells by disrupting protein degradation pathways and is manufactured under GMP standards for injectable formulations.
Carfilzomib API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 5 (Page 1 of 1)
CAT No.: AS03929
CAS No.: 771-61-9
Category: Metabolites
Parent API: Carfilzomib
Mol. Formula: C9H13NO2
Mol. Wt.: 184.07
CAT No.: AS04014
CAS No.: 1672698-96-2
Category: Impurities
Parent API: Carfilzomib
Mol. Formula: C40H58ClN5O7
Mol. Wt.: 735.91
CAT No.: AS04015
CAS No.: 1541171-67-8
Category: Impurities
Parent API: Carfilzomib
Mol. Formula: C17H19N5O2
Mol. Wt.: 756.38
CAT No.: AS04013
CAS No.: 868540-17-4
Category: Working Standards
Parent API: Carfilzomib
Mol. Formula: C40H57N5O8
Mol. Wt.: 719.91
CAT No.: AS03167
CAS No.: 82732-07-8
Category: Impurities
Parent API: Carfilzomib
Mol. Formula: C15H11BrClNO
Mol. Wt.: 279.34
